Publications
5674 Results
- Journal / Conference
- International Conference on Malignant Lymphoma, 11th annual meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0350
Phase II trial of cisplatin plus etoposide plus gemcitabine plus solumedrol (PEGS) in peripheral T-cell non-Hodgkin lymphoma (SWOG S0350)
- Journal / Conference
- Journal of Clinical Oncology, 29(33):4417-23;
- Year
- 2011
- Research Committee(s)
- Leukemia
- PMID
- PMID21969499
- PMC
- PMC3221524
- Study Number(s)
- S0106, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918
Prediction of early death following induction therapy for newly diagnosed acute leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
- Journal / Conference
- Blood 118(21):abstract 430; American Society of Hematology Annual Meeting, oral presentation;
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496
A gene expression signature in diagnostic formalin fixed paraffin embedded tissue predicts overall survival in locally advanced and advanced stage classical hodgkin lymphoma - a correlative study from the E2496 intergroup trial
- Journal / Conference
- Blood 118(21):abstract 87; American Society of Hematology Annual Meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Gene risk scores based on expression of 6 genes quantitated by nuclease protein assay in formalin fixed paraffin-embedded DLBCL specimens from CHOP and RCHOP treated patients predicts outcome: an ECOG and SWOG study
- Journal / Conference
- International Journal of Radiation Oncology, Biology & Physics 79(2):481-489
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID20400244
- PMC
- PMC2929319
- Study Number(s)
- S0713
Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting [PMID20400244; PMC2929319]
- Journal / Conference
- Journal of Clinical Oncology 29(34):4491-4497
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- N9831
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer [PMID22042958; PMC3236650]
- Journal / Conference
- Annals of Surgical Oncology 18(5):1319-1326
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- R9704
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trials [PMID21499862]
- Journal / Conference
- Lancet Oncology 12(13):1195-1203
- Year
- 2011
- Research Committee(s)
- Myeloma
- PMID
- PMID21962393
- PMC
- PMC3611089
- Study Number(s)
- CTN 0102
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial
- Journal / Conference
- Journal of Clinical Oncology 29:2011 (suppl; abstr 4003); ASCO 2011 Meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
Postoperative adjuvant chemoradiation for gastric or gstroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101
- Journal / Conference
- AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics (no abstract; invited presentation)
- Year
- 2011
- Research Committee(s)
- Multiple sites